Shaping Oncogenic Microenvironments: Contribution of Fibronectin

Area of Science:

• Oncology
• Biophysics
• Cell Biology

Background:

• The extracellular matrix (ECM) is a dynamic network crucial for organ structure and function.
• Cancer progression involves both cell-intrinsic mutations and extrinsic factors like the tumor microenvironment and ECM biophysics.
• ECM remodeling during cancer includes basal lamina disruption, vascular invasion, and fibrosis, leading to increased tissue stiffness.

Purpose of the Study:

• To review the interactions and signaling pathways involving fibronectin in tumorigenesis and metastasis.
• To provide molecular insights into how fibronectin contributes to cancer progression.
• To aid in predicting therapy response based on fibronectin's role.

Main Methods:

• Literature review focusing on ECM remodeling in cancer.
• Analysis of signaling pathways involving fibronectin and cancer-associated fibroblasts (CAFs).
• Exploration of fibronectin's role in promoting tumor cell de-differentiation, proliferation, and invasion.

Main Results:

• Increased tissue stiffness due to ECM remodeling potentiates malignant transformation.
• Cancer-associated fibroblasts (CAFs) are key players, secreting fibronectin and type I collagen.
• Fibronectin secreted by CAFs significantly supports tumorigenesis and metastasis.

Conclusions:

• The fibrotic microenvironment, particularly fibronectin, plays a critical role in cancer progression.
• Understanding fibronectin's pro-tumorigenic mechanisms is vital for developing targeted therapies.
• Molecular insights into fibronectin signaling can improve therapy response prediction in cancer patients.